Correlation Between Virtus Emerging and Biotechnology Ultrasector

Can any of the company-specific risk be diversified away by investing in both Virtus Emerging and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virtus Emerging and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virtus Emerging Markets and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Virtus Emerging and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virtus Emerging with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virtus Emerging and Biotechnology Ultrasector.

Diversification Opportunities for Virtus Emerging and Biotechnology Ultrasector

0.34

Correlation Coefficient

Virtus Emerging  Biotechnology Ultrasector

Weak diversification

The 3 months correlation between Virtus and Biotechnology is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Virtus Emerging Markets and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Virtus Emerging is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virtus Emerging Markets are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Virtus Emerging i.e., Virtus Emerging and Biotechnology Ultrasector go up and down completely randomly.

Pair Corralation between Virtus Emerging and Biotechnology Ultrasector

Assuming the 90 days horizon Virtus Emerging Markets is expected to generate 0.26 times more return on investment than Biotechnology Ultrasector. However, Virtus Emerging Markets is 3.88 times less risky than Biotechnology Ultrasector. It trades about 0.01 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about -0.05 per unit of risk. If you would invest  1,602  in Virtus Emerging Markets on September 13, 2024 and sell it today you would earn a total of  4.00  from holding Virtus Emerging Markets or generate 0.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Virtus Emerging Markets  vs.  Biotechnology Ultrasector Prof

Virtus Emerging Markets

Risk-Adjusted Performance

0 of 100

Insignificant

Over the last 90 days Virtus Emerging Markets has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Virtus Emerging is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Ultrasector

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pair Trading with Virtus Emerging and Biotechnology Ultrasector

The main advantage of trading using opposite Virtus Emerging and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virtus Emerging position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.

The idea behind Virtus Emerging Markets and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.